MUMBAI, INDIA - JULY 11: New born babies on the World Population Day at Wadia Hospital at Parel, on July 11, 2017 in Mumbai, India. World Population Day is an annual event, observed on July 11 every year, which seeks to raise awareness of global population issues. The event was established by the Governing Council of the United Nations Development Programme in 1989. It was inspired by the public interest in Five Billion Day on July 11, 1987 - approximately the date on which the world's population reached five billion people. (Photo by Kunal Patil/Hindustan Times via Getty Images)
The incidence of sepsis in newborns is high in India. Start-up Avyantra is developing an algorithm that can help predict it © Getty

When Geetha Manjunath lost a family member to breast cancer, she resolved to use her IT skills to help fight the disease.

“When my cousin went to the doctor, the cancer was already at an advanced stage, which made the treatment challenging,” says Manjunath, whose company Niramai uses artificial intelligence-powered thermal imaging to improve early detection of tumours.

The non-invasive test, which Manjunath says can be performed by a low-skilled healthcare worker and does not require a hospital, generates a provisional report within 15 minutes, using AI to read the thermal image’s colour points.

The test costs about $20 in a hospital — less than half the price of a mammogram in India — while many rural patients are offered the test at a subsidised rate of less than $2, Manjunath says.

Geetha Manjunath, whose company Niramai developed a low-cost screening tool that uses AI to detect breast cancer
Geetha Manjunath, whose company Niramai developed a low-cost screening tool that uses AI to detect breast cancer

Such AI-led groups are becoming commonplace across India’s healthcare industry. When the Centre for Internet and Society, a non-profit research group, reviewed the country’s AI-led healthcare initiatives, it found that the main focus was to extend medical services to traditionally underserved populations in India. “AI . . . in healthcare in India appears to be addressing issues of economic disparity rather than widening existing gaps,” the CIS report says.

Two-thirds of India’s population lives in rural areas but is served by one-third of the country’s doctors, according to World Bank data. This statistic that has encouraged innovative companies to use AI to remedy the shortfall by helping low-skilled health workers diagnose medical conditions.

Sattva MedTech, an Indian medical start-up, is using AI-powered electrocardiogram-based monitoring systems to diagnose foetal distress — a condition that contributes to India’s high neonatal mortality rate.

Vibhav Joshi, chief executive and co-founder, says the group’s technology — which received a $100,000 grant from the Bill & Melinda Gates Foundation to develop algorithms and conduct a pilot study — can be used by low-skilled healthcare staff.

An AI-powered foetal monitor developed by start-up Sattva MedTech
An AI-powered foetal monitor developed by start-up Sattva MedTech

“[Many rural] health centres don’t have foetal monitoring systems and even if they have the conventional doppler test, they don’t have the skilled personnel to conduct the investigation,” says Joshi. Sattva MedTech says its AI has a 93 per cent detection rate of foetal distress and is targeting 98 per cent before it starts offering the algorithm commercially.

Hyderabad-based Avyantra, a medical start-up, is developing an algorithm that it hopes can predict sepsis in newborns based on the mother’s risk factors and the baby’s medical parameters.

India has the world’s highest incidence of clinical sepsis — 17,000 cases reported for every 100,000 live births — and Hyma Goparaju, Avyantra co-founder, believes the group’s technology can encourage better use of antibiotics in newborns and reduce sepsis-related deaths.

“We have identified about 30 parameters such as blood pressure and colour of the newborn’s skin,” she says. “The AI then generates a score which the health worker can use to decide [based on a risk score] if the newborn needs to be shifted to a hospital.”

Avyantra has received $100,000 funding from Unicef, the UN’s agency for children, to further develop its algorithm and is hoping to test its technology in the field.

Though these start-ups offer hope of providing timely, quality healthcare, critics worry about data privacy and the sensitivity of predictive AI, which are not always validated by regulators or independent reviewers.

No rules prevent hospitals from sharing data with companies developing AI for healthcare, says Vidur Mahajan, a member of the Indian Council of Medical Research’s committee dedicated to developing ethical guidelines for AI research.

India also lacks a regulatory watchdog solely dedicated to reviewing AI-powered healthcare companies, with the task currently falling to the Central Drugs Standard Control Organisation, a drug and medical device regulating authority.

“When my company started working with AI developers, we decided to explicitly take consent from patients for using their data for AI development,” says Mahajan, who also heads research and development at Mahajan Imaging, a diagnostic and imaging facility based in New Delhi. “In terms of regulation, software is not treated like a drug in India.”

Copyright The Financial Times Limited 2024. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this article